Zepbound leads to more weight loss than Wegovy, drugmaker Eli Lilly says ...Middle East

News channel - News
Zepbound leads to more weight loss than Wegovy, drugmaker Eli Lilly says
By Deidre McPhillips, CNN (CNN) — Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from drugmaker Eli Lilly. In a head-to-head comparison of the two GLP-1 drugs, adults living with obesity or overweight who were taking Zepbound, the brand name for tirzepatide, lost more than 20% of their weight on average after about a year and half, compared with an average of about 14% weight loss among those taking Wegovy, the brand name for semaglutide. That translates to an average weight loss of about 50 pounds for those taking Zepbound, compared with an average weight loss of 33 pounds for those taking Wegovy. People taking Zepb

Hence then, the article about zepbound leads to more weight loss than wegovy drugmaker eli lilly says was published today ( ) and is available on News channel ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Zepbound leads to more weight loss than Wegovy, drugmaker Eli Lilly says )

Apple Storegoogle play

Last updated :

Also on site :



Latest News